THE IMPACT OF DRUG LEVELS TO ANTI-TNF AND ANTI-INTEGRIN AGENTS ON COVID-19 VACCINE RESPONSE IN PATIENTS WITH IBD

Jayne Doherty  ¹     Roisin Stack  ²     Neil O´Morain  ²     Miriam Tosetto  ²     Rosanna Inzitari  ³     David J. Daghfal  ⁴     Peter Doran  ⁴     Colm O'Morain  ⁵     Glen A Doherty  ^5    
1 St Vincent's Hospital, Dublin, Ireland
² St. Vincent's University Hospital, Dublin, Ireland
³ University College Dublin, Dublin, Ireland
⁴ Abbott Laboratories, Lake Forest, IL, United States
⁵ Trinity College Dublin - Faculty of Health Sciences, Trinity College Dublin, Dublin/IE, Dublin

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)